The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus
Latest Information Update: 24 Jan 2023
At a glance
- Drugs Dapagliflozin (Primary) ; Empagliflozin (Primary)
- Indications Atrial fibrillation; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Jan 2023 Status changed from not yet recruiting to recruiting.
- 07 Sep 2021 New trial record